Literature DB >> 10748325

Masculinizing effects on otoacoustic emissions and auditory evoked potentials in women using oral contraceptives.

D McFadden1.   

Abstract

The otoacoustic emissions (OAEs) and auditory evoked potentials (AEPs) measured in two separate large scale studies were examined retrospectively for potential differences between those women using, and those not using, oral contraception (OC). Fourteen dependent variables were examined, all of which exhibited substantial sex differences. For 13 of those 14 dependent variables, the means for the users of OC were shifted away from the means of the non-users in the direction of the males. Specifically, for four different measures of OAE strength, for seven of eight measures of AEP latency or amplitude, and for two cognitive tests (mental rotation and water level), the means for the users of OC were located intermediate to those of the non-users of OC and the males. Few of these differences between users and non-users of OC achieved statistical significance, but the near universality of the direction of the difference suggests that oral contraceptives do produce a weak masculinizing effect on some auditory structures. These weak masculinizing effects appear to run contrary to the facts that the levels of both free testosterone and estradiol are lower in women using OC than in normal-cycling women. Past findings on auditory sex differences may have underestimated those sex differences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748325     DOI: 10.1016/s0378-5955(00)00002-2

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  16 in total

1.  Differences by sex, ear, and sexual orientation in the time intervals between successive peaks in auditory evoked potentials.

Authors:  Dennis McFadden; Michelle D Hsieh; Adrian Garcia-Sierra; Craig A Champlin
Journal:  Hear Res       Date:  2010-09-27       Impact factor: 3.208

Review 2.  Sexual orientation and the auditory system.

Authors:  Dennis McFadden
Journal:  Front Neuroendocrinol       Date:  2011-02-12       Impact factor: 8.606

Review 3.  The effects of ethinylestradiol and progestins ("the pill") on cognitive function in pre-menopausal women.

Authors:  Andrea Gogos; YeeWen Candace Wu; Amy S Williams; Linda K Byrne
Journal:  Neurochem Res       Date:  2014-09-30       Impact factor: 3.996

4.  Differences in common psychoacoustical tasks by sex, menstrual cycle, and race.

Authors:  Dennis McFadden; Edward G Pasanen; Mindy M Maloney; Erin M Leshikar; Michelle H Pho
Journal:  J Acoust Soc Am       Date:  2018-04       Impact factor: 1.840

5.  Sex differences in auditory subcortical function.

Authors:  Jennifer Krizman; Erika Skoe; Nina Kraus
Journal:  Clin Neurophysiol       Date:  2011-09-08       Impact factor: 3.708

6.  Relationships between otoacoustic emissions and a proxy measure of cochlear length derived from the auditory brainstem response.

Authors:  Dennis McFadden; Adrian Garcia-Sierra; Michelle D Hsieh; Mindy M Maloney; Craig A Champlin; Edward G Pasanen
Journal:  Hear Res       Date:  2012-04-21       Impact factor: 3.208

Review 7.  Masculinization of the mammalian cochlea.

Authors:  Dennis McFadden
Journal:  Hear Res       Date:  2009-01-20       Impact factor: 3.208

8.  Otoacoustic emissions, auditory evoked potentials and self-reported gender in people affected by disorders of sex development (DSD).

Authors:  Amy B Wisniewski; Blas Espinoza-Varas; Christopher E Aston; Shelagh Edmundson; Craig A Champlin; Edward G Pasanen; Dennis McFadden
Journal:  Horm Behav       Date:  2014-07-16       Impact factor: 3.587

9.  Effect of prenatal androgens on click-evoked otoacoustic emissions in male and female sheep (Ovis aries).

Authors:  Dennis McFadden; Edward G Pasanen; Michelle D Valero; Eila K Roberts; Theresa M Lee
Journal:  Horm Behav       Date:  2008-09-12       Impact factor: 3.587

10.  Estrogen receptor beta protects against acoustic trauma in mice.

Authors:  Inna Meltser; Yeasmin Tahera; Evan Simpson; Malou Hultcrantz; Konstantina Charitidi; Jan-Ake Gustafsson; Barbara Canlon
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.